Interleukin-1β mediates virus-induced M2 muscarinic receptor dysfunction and airway hyperreactivity

American Journal of Respiratory Cell and Molecular Biology

Volumn 51, Issue 4, 2014, Pages 494-501

  Rynko, Abby E ^a   Fryer, Allison D ^b   Jacoby, David B ^b  

^a Department of Molecular Microbiology and Immunology ^*  (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Asthma; IL 1 ; Parainfluenza virus; Parasympathetic nerves; TNF

Indexed keywords

PARAINFLUENZA VIRUS;

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MUSCARINIC M2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CHOLINERGIC SYSTEM; DISEASE MODEL; DRUG EFFECTS; GUINEA PIG; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INHALATION TEST; INNERVATION; LUNG; METABOLISM; PARAMYXOVIRIDAE; PARAMYXOVIRUS INFECTION; PATHOGENICITY; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFECTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GUINEA PIGS; HOST-PATHOGEN INTERACTIONS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; LUNG; PARAMYXOVIRIDAE; PARAMYXOVIRIDAE INFECTIONS; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTOR, MUSCARINIC M2; RESPIRATORY TRACT INFECTIONS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907515405     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0009OC     Document Type: Article

References (40)

1. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-1229.
2. Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, Greenberg SB. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998;158:2453-2459.
3. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131-139.
4. Aquilina AT, Hall WJ, Douglas RGJ Jr, Utell MJ. Airway reactivity in subjects with viral upper respiratory tract infections: the effects of exercise and cold air. Am Rev Respir Dis 1980;122: 3-10.
5. Johanson WGJ Jr, Pierce AK, Sanford JP. Pulmonary function in uncomplicated influenza. Am Rev Respir Dis 1969;100:141-146.
6. Nadel JA, Barnes PJ. Autonomic regulation of the airways. Annu Rev Med 1984;35:451-467.
7. Haddad EB, Landry Y, Gies JP. Muscarinic receptor subtypes in guinea pig airways. Am J Physiol 1991;261:L327-L333.
8. Roffel AF, Elzinga CR, Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990;3:47-51.
9. Fryer AD, Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1984;83: 973-978.
10. Fryer AD, Jacoby DB. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1991;102:267-271.
11. Fryer AD, Wills-Karp M. Dysfunction of M2-muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge. J Appl Physiol (1985) 1991;71:2255- 2261.
12. Minette PA, Lammers JW, Dixon CM, McCusker MT, Barnes PJ. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol (1985) 1989;67: 2461-2465.
13. Fryer AD, Yarkony KA, Jacoby DB. The effect of leukocyte depletion on pulmonary M2 muscarinic receptor function in parainfluenza virusinfected guinea-pigs. Br J Pharmacol 1994;112:588-594.
14. Bowerfind WM, Fryer AD, Jacoby DB. Double-stranded RNA causes airway hyperreactivity and neuronal M2 muscarinic receptor dysfunction. J Appl Physiol (1985) 2002;92:1417-1422.
15. Jacoby DB, Xiao HQ, Lee NH, Chan-Li Y, Fryer AD. Virus- and interferon-induced loss of inhibitory M2 muscarinic receptor function and gene expression in cultured airway parasympathetic neurons. J Clin Invest 1998;102:242-248.
16. Grodzki AC, Ghogha A, Mangini L, Fryer AD, Lein PJ. IFNg increases M2 muscarinic receptor expression in cultured sympathetic neurons. Curr Neurobiol 2011;2:23-29.
17. Nie Z, Jacoby DB, Fryer AD. Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. Br J Pharmacol 2009; 156:201-210.
18. Nie Z, Scott GD, Weis PD, Itakura A, Fryer AD, Jacoby DB. Role of TNF-a in virus-induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction. Br J Pharmacol 2011;164: 444-452.
19. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-967.
20. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J Immunol 1992;149: 3078-3082.
21. Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995; 152:1474-1477.
22. Sousa AR, Lane SJ, Nakhosteen JA, Lee TH, Poston RN. Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 1996;154:1061-1066.
23. Verhein KC, Jacoby DB, Fryer AD. IL-1 receptors mediate persistent, but not acute, airway hyperreactivity to ozone in guinea pigs. Am J Respir Cell Mol Biol 2008;39:730-738.
24. Selig W, Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol 1992;213:331-336.
25. Hua J, Liao MJ, Rashidbaigi A. Cytokines induced by Sendai virus in human peripheral blood leukocytes. J Leukoc Biol 1996;60:125-128.
26. Yoshizumi M, Kimura H, Okayama Y, Nishina A, Noda M, Tsukagoshi H, Kozawa K, Kurabayashi M. Relationships between cytokine profiles and signaling pathways (IkB kinase and p38 MAPK) in parainfluenza virus-infected lung fibroblasts. Front Microbiol 2010;1:124.
27. Li XQ, Fu ZF, Alvarez R, Henderson C, Tripp RA. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J Virol 2006;80:537-540.
28. Liu Y, Haas DL, Poore S, Isakovic S, Gahan M, Mahalingam S, Fu ZF, Tripp RA. Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment. J Virol 2009;83:6837-6848.
29. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y. Parainfluenza virus type 1 infects olfactory neurons and establishes longterm persistence in the nerve tissue. J Gen Virol 1995;76:1251-1254.
30. Lee AM, Fryer AD, van Rooijen N, Jacoby DB. Role of macrophages in virus-induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction. Am J Physiol Lung Cell Mol Physiol 2004;286:L1255-L1259.
31. Haddad EB, Rousell J, Lindsay MA, Barnes PJ. Synergy between tumor necrosis factor alpha and interleukin 1beta in inducing transcriptional down-regulation of muscarinic M2 receptor gene expression: involvement of protein kinase A and ceramide pathways. J Biol Chem 1996;271:32586-32592.
32. Keen H, Hurst V, Jack S. Loss of function of pulmonary neuronal M2 receptors in subjects with mild bronchial hyperreactivity during a respiratory tract viral infection. Eur Respir J 1998;12:149S.
33. Dolan CM, Fraher KE, Bleecker ER, Borish L, Chipps B, Hayden ML, Weiss S, Zheng B, Johnson C, Wenzel S; TENOR Study Group. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: A large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2004;92:32-39.
34. Holgate ST, Holloway J, Wilson S, Howarth PH, Haitchi HM, Babu S, Davies DE. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol 2006; 117:496-506, quiz 507.
35. Chanez P, Wenzel SE, Anderson GP, Anto JM, Bel EH, Boulet LP, Brightling CE, Busse WW, Castro M, Dahlen B, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 2007;119:1337-1348.
36. Wenzel S, Szefler SJ. Managing severe asthma. J Allergy Clin Immunol 2006;117:508-511.
37. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2006;117:522-543.
38. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W, Beckett P, Al-Ali M, Chauhan A, Wilson SJ, et al. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005;60:1012-1018.
39. Cazzola M, Polosa R. Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma. Curr Opin Allergy Clin Immunol 2006;6:43-50.
40. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006;354:697-708.